Browse Studies — Arctuva

Phase 1

The Role of Bimatoprost in Graves' Periorbitopathy

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Graves Ophthalmopathy

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT03708627

Prospective Observational Study of Smartphone-Based Self-Monitoring Using an Artificial Intelligence Solution During Non-Surgical Treatment for Thyroid Eye Disease

This prospective observational study evaluates the feasibility and clinical utility of a smartphone-based artificial intelligence (AI) self-monitoring system i…

Thyroid Eye Disease (TED)Graves OphthalmopathyThyroid Associated Ophthalmopathies

Estimated

~$10 – $1,050

THYROSCOPE INC.NCT07623993

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam l…

Thyroid Eye DiseaseGraves OphthalmopathyGraves Disease

Estimated

~$10 – $750

Walter Reed National Military Medical CenterNCT06275373

Phase 2

A Multicenter, Extension Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

The overall study objective is to continue to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of linsitinib in subjects who were enrolled i…

Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more

Estimated

~$10 – $8,750

Sling Therapeutics, Inc.NCT06112340